Event Registration Link: //https://www.emedevents.com/herhealth-oncology-cme-conference-newyork-2026
#HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics is a premier hybrid CME/CE conference dedicated to advancing the understanding and clinical management of cancers affecting women. Scheduled for October 9–10, 2026, in New York City, this 1.5-day conference will bring together leading oncologists, gynecologic oncologists, researchers, and multidisciplinary healthcare professionals to explore the latest developments in diagnosis, targeted therapies, biomarker-driven treatment strategies, and emerging technologies in women’s oncology.
The conference will focus on key malignancies affecting women, including breast cancer, ovarian cancer, endometrial cancer, cervical cancer, and rare gynecologic cancers such as fallopian tube, vaginal, and vulvar cancers. Through expert-led sessions, panel discussions, and case-based learning, the program will address current challenges in clinical practice and highlight emerging treatment strategies that are transforming oncology care.
Conference Highlights:
Networking:
#HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics provides an opportunity to connect with leading experts in breast and gynecologic oncology, including oncologists, researchers, and multidisciplinary healthcare professionals. Engage in meaningful discussions, exchange clinical insights on emerging therapies, biomarker-driven treatments, and precision oncology, and build collaborations that support innovation and improved outcomes for women with cancer.
Session Insights:
Explore focused sessions covering key advances in breast cancer and gynecologic malignancies, including ovarian, endometrial, cervical, and rare cancers. #HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics will feature expert-led discussions on biomarker-driven therapies, antibody-drug conjugates, targeted treatments, immunotherapy, and emerging technologies such as artificial intelligence in oncology, highlighting clinical evidence and practical strategies that can be integrated into patient care.
Target Audience:
#HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics welcomes a multidisciplinary audience involved in the care of women with cancer, including medical oncologists, gynecologic oncologists, hematologist-oncologists, OB/GYN physicians, oncology nurses, nurse practitioners, physician assistants, oncology pharmacists, researchers, and other healthcare professionals committed to advancing the diagnosis, treatment, and management of breast and gynecologic malignancies.
Credits:
#HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics is accredited by eMedEd, an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME) and continuing education by the California Board of Registered Nursing (CBRN), offering CME for physicians and CE for nurses. This program is accredited for 10 AMA PRA Category 1 Credits™ and 10 ABIM MOC Credits for physicians and 10 contact hours for nurses.
Conference Topics:
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Cervical Cancer
Rare Cancers (Fallopian, Vaginal, and Vulvar Cancer)
AI in Oncology
Precision Oncology
Biomarker-driven Therapy Selection
Antibody-drug Conjugates (ADCs)
Immune Checkpoint Inhibitors
